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The use of vaginal mesh in pelvic organ prolapse (POP) repair surgery has become more common in recent years. The purpose of
the current study was to evaluate the common practice of Israeli urogynecologists, and to determine whether surgical practice has
changed over the last two years. Methods. In 2009 and again in 2011, a survey was mailed to all urogynecologists aﬃliated with an
academic institute in Israel. The survey consisted of 7 Likert-scale items and 3 open questions; the latter inquired about preferred
type of surgery in three clinical scenarios. Results. Of 22 practitioners, 15 responded to the survey. The number of urogynecologists
who reported using vaginal mesh for the repair of primary POP increased from 47 to 67% from 2009 to 2011. The number who
would not use vaginal mesh in POP repair of elderly patients dropped from 60 to 3%. Finally, for the treatment of a 35-year-
old patient with stage III uterine prolapse who desired to preserve fertility, 13% recommended the used vaginal mesh in 2009
compared with 47% in 2011. Conclusion. A survey of practitioners shows that the use of vaginal mesh for the repair of primary
and recurrent pelvic organ prolapse has become more common among Israeli urogynecologists.
1.Introduction
The use of vaginal mesh in pelvic organ prolapse repair
surgeryhasrecentlybecomemorecommon[1].Anumberof
prolapse repair mesh devices have been designed by diﬀerent
companies and marketed extensively as a minimally invasive
approach to pelvic ﬂoor repair. A Cochrane Collaboration
review entitled “Surgical management of pelvic organ prolapse
in women,” and based on 3773 patients in 40 trials,
was published in 2010 [2]. The authors concluded that
abdominal sacral colpopexy is associated with a lower rate
of recurrent vault prolapse (RR 0.23, 95% CI 0.07–0.77)
and dyspareunia (RR 0.39, 95% CI 0.18–0.86) than vaginal
sacrospinous colpopexy, though the latter was found to have
a shorter operating time. The use of mesh or graft inlays at
the time of anterior vaginal wall repair was found to reduce
theriskofrecurrentanteriorwallprolapse.Standardanterior
repair was associated with more anterior compartment
failures on examination than was polypropylene mesh repair
as an overlay (RR 2.14, 95% CI 1.23 to 3.74) or armed
transobturator mesh (RR 3.55, 95% CI 2.29 to 5.51) [2].
However, due to the paucity of peer-reviewed manuscripts,
the authors advised relating to this procedure with caution.
Reliablelong-termdataontheeﬀectofvaginalmeshinpelvic
organ prolapse surgery is particularly lacking.
Subsequent to a metaanalysis of the use of vaginal
mesh in pelvic organ prolapse repair surgery, the Society2 Obstetrics and Gynecology International
of Gynecologic Surgeons Systematic Review Group (SGS-
SRG) issued two publications, “Clinical practice guidelines
on vaginal graft use”[ 3]a n d“ Graft use in transvaginal
pelvic organ prolapse repair, a systematic review”b yS u n g
et al. [4]. The objective of the former was to establish
guidelines regarding the employment of synthetic grafts or
native tissue repair in POP repair [3]. Weak evidence was
found for the superiority of native tissue repair in anterior
vaginal wall repair, when compared with biologic graft (4
trials). Weak evidence was also found for the superiority
of native tissue repair in anterior vaginal wall repair, when
compared with absorbable synthetic graft (2 trials) [3].
Moreover, weak evidence was found for nonabsorbable
synthetic mesh improving anatomic outcomes of anterior
vaginal wall repair, albeit with signiﬁcant tradeoﬀsi nr e g a r d
to the risk of adverse events (2 trials). Regarding the
superiority of native tissue repair for posterior prolapse
versus absorbable synthetic graft or biologic graft, evidence
was also weak (3 trials). Finally, no comparative studies
were found that addressed the use of biologic grafts in
multiple compartment repair compared with native tissue
repair; the use of absorbable synthetic graft in multiple
compartment vaginal wall repair compared with native
tissue repair, or the use of nonabsorbable synthetic graft in
multiple compartment repair compared with native tissue
repair [3]. In conclusion, the authors noted that while the
data supporting a lower rate of prolapse recurrence in graft
use is limited, physicians should nevertheless consider and
communicate to patients the seemingly improved durability
of the procedure in the face of potential adverse events [4].
Due to the insuﬃcient evidence, from a medical-legal
point of view, the best course of action regarding the use of
vaginal mesh in POP is a matter of debate. Some advocate
that distinct informed consent be obtained for the use of
vaginal mesh [5]. However, in a letter to the editor, Ann
Weber states, “obtaining informed consent from patients for
vaginal mesh placement during prolapse surgery cannot be
achieved in light of the current dearth of data regarding
risks and beneﬁts [6],” and suggests that such procedures be
regarded as “experimental.”
Despite the paucity of peer-reviewed studies on the use
of vaginal mesh in pelvic ﬂoor prolapse repair, professional
interest seems on the rise in recent years. A search of the
PubMed database for the keywords “vaginal mesh” yields
118 articles published in 2009, 98 in 2010, and 53 as of July
2011, in all languages. These include randomized trials, basic
science (e.g., ultrasound, histology, and animal models), case
reports, retrospective series, guidelines, professional surveys,
and reviews.
The purpose of the current study was to evaluate the
common practice of Israeli urogynecologists, and to evaluate
trends in the practice of pelvic organ prolapse repair during
the last two years.
2.MaterialsandMethods
An electronic survey was mailed to all fellowship-trained
urogynecologists aﬃliated with an academic institute in
Israel, in 2009 and again in 2011. The survey consisted of
7 Likert-scale score items and 3 open questions. Possible
responses to the 7-point Likert-score questions ranged
from “none of the time” to “all of the time.” Subjects
included general mesh use; mesh use in light of comorbidity
(diabetes, menopause, and stress urinary incontinence); and
considerations of other factors (sexual activity, fertility). See
The appendix for the full questionnaire. The open questions
inquired about preferred type of surgery in three clinical sce-
narios. Participants were instructed not to consider ﬁnancial
factors in their decision making. Surveys were mailed back
anonymously.
3.StatisticalAnalysis
SPSS for Windows version 18 (SPSS, Inc., Chicago, IL) was
used for data management and statistical analysis. The chi-
square test was used for comparison between dependent
groups of categorical variables. All tests were considered
signiﬁcant at the .05 level. All tests were 2 sided.
4. Results
The response rate of those who answered both in 2009
and 2011 was 68% (15/22). An increase in the number
of urogynecologists who reported “frequently” or “almost
always” using vaginal mesh for the repair of primary
POP increased from 47 to 67%. Similarly, for recurrent
POP, the number who would use vaginal mesh increased
from 80 to 93%. For women older than 70 years, 60%
of urogynecologists in 2009 compared with 33% in 2011
stated that they will rarely or never use meshes for POP
repair.
Regarding a case of a 55-year-old sexually active woman
with uterine prolapse stage III, there was no change in the
practice of the surveyed urogynecologists, with none of the
participants choosing to perform abdominal or laparoscopic
surgery, instead participants recommended vaginal hysterec-
tomy and apical suspension with or without graft insertion.
Regarding an 80-year-old healthy women with procidentia,
only 13% chose to perform colpocleisis in 2009 compared
with 47% in 2011 (P<0.001). Finally, regarding the
case of a 35-year-old patient with stage III uterine prolapse
who desired to preserve fertility, 2 (13%) recommended
Manchester surgery with the insertion of vaginal mesh in
2009 while 7 (47%) recommended the use of mesh in 2011,
with only one of them recommending Manchester surgery
(P<0.001).
5. Discussion
This survey shows an increasing trend in the use of vaginal
mesh for pelvic organ prolapse (POP) repair by Israeli pelvic
ﬂoor surgeons over the last two years. This was apparent forObstetrics and Gynecology International 3
primary and recurrent POP repair, as well as for POP repair
in patients presenting with concomitant disease, menopause,
or lifestyle considerations. Importantly, in women desiring
preservationoffertility,thereappearstobeamarkedincrease
in the use of mesh in hysteropexy, which may reﬂect on
increase in documentation of favorable results pertaining
to pregnancy [7, 8] .T h er e p o r t e di n c r e a s ei nt h eu s eo f
colpocleisis may result from current training of physicians,
andincreasedcautionbyurogynecologistsregardingpossible
mesh complications in the elderly population.
The use of vaginal meshes in POP repair has increased
in Israel despite the lack of randomized controlled trials
supporting such use, and despite seemingly unresolved legal
complications regarding the extent of patients’ consent.
The latter issue is not merely a technicality—long-term
stability and risks of complications from these procedures
are as yet unknown. Nevertheless, the reasons for the
growing popularity of vaginal mesh are varied. First, Israeli
surgeons practice medicine in an environment characterized
by innovation and scientiﬁc progress, exempliﬁed by Israel’s
reputation as a world leader of biotechnological research
and development. Second, the boon of new mesh products,
accompaniedbypowerfulmarketingeﬀorts,hasmadeawide
array of vaginal mesh products available to surgeons. Third,
experience and mastery of the use of vaginal meshes may
alleviatepreviousreservationsinfavorofthenewtechnology.
Fourth, and perhaps of prime importance, the ease of use
of the new mesh products, along with physicians’ own
experience about better durability in POP repair with mesh
compared with native tissue, is making them lucrative for
most gynecologists.
The use of a nonvalidated questionnaire is a limitation
of the current study. Further, its anonymity precluded
assessment of such characteristics of urogynecologists as
number of years in practice and place of training. Most
importantly, we have no data regarding the number of
v a g i n a lm e s hp r o c e d u r e st h a tw e r ea c t u a l l yp e r f o r m e db y
each gynecologist, which may constitute a reporting bias on
the part of the respondents.
6. Conclusion
The survey reported herein demonstrates a recent increase
in the popularity of vaginal mesh use for the repair of pelvic
organ prolapse among Israeli urogynecologists.
Randomized controlled trials of the use of vaginal mesh
for POP repair are needed to determine optimal indications
for their use. In the meantime, caution should be advised in
the application of this yet unproven technology [4].
Appendix
SurveyQuestionnaire
Questions 1–3 pertain to women referred due to stage 3
prolapse of at least one compartment.
Always Never
54 3 2 10
( 1 )U s eo fv a g i n a lm e s hi n
primary POP repair 54 3 2 10
( 2 )U s eo fv a g i n a lm e s hi n
recurrent POP repair 54 3 2 10
(3) Would you use a vaginal
mesh in a patient who is
disinterested in sexual
intercourse?
54 3 2 10
(4) Would you use a vaginal
mesh in women over 70 years
of age?
54 3 2 10
(5) Do you consider insulin
dependent diabetes mellitus a
contraindication to vaginal
mesh use?
54 3 2 10
(6) In a menopausal patient
with a stage III prolapse of one
vaginal wall and stage II
uterine prolapse, would you
prefer to preserve the uterus?
54 3 2 10
(7) In a menopausal patient
with stage I uterine prolapse
and stage III elongation of
uterine cervix, would you
prefer to preserve the uterus?
54 3 2 10
(8) A healthy, physically, and sexually active 55 year
old. Diagnosis: stage III uterine prolapse, stage III
cystocele, gaping introitus, stress urinary incontinence.
Your choice of procedure: ..............................
(9) A healthy 80-year-old patient who is not sexually
active. Diagnosis: total prolapse.
Your choice of procedure: ..............................
(10) A 35-year-old woman desiring preservation of
fertility. Diagnosis: stage III uterine prolapse, stage II
cystocele, stage II rectocele (pessary treatment failed).
Your choice of procedure: ..............................
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